topic-orcrp006545 News Coverage on GlaxoSmithKline PLC - CTNow
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 45-55
  • For Diabetes Drug Avandia, Bad News Continues

    For Diabetes Drug Avandia, Bad News Continues
    The diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke....
  • Experts Vote to Keep Avandia

    Experts Vote to Keep Avandia
    U.S. health advisers said GlaxoSmithKline Plc's GSK.L diabetes drug Avandia should be allowed to stay on the market in some form, easing a threat of further litigation that could have followed a ban. The 33-member panel of outside experts convened by the...
  • FDA: Avandia Should Stay With Restrictions

    FDA: Avandia Should Stay With Restrictions
    Faced with conflicting and less-than-conclusive scientific evidence, a Food and Drug Administration advisory panel recommended Wednesday that the controversial diabetes drug Avandia remain on the market — but with tighter supervision and increased...
  • Glaxo adds safety restrictions to Avandia label

    Glaxo adds safety restrictions to Avandia label
    WASHINGTON (AP) -- GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack. The Food and Drug Administration...
  • Men taking erectile dysfunction drugs risk STDs

    Men taking erectile dysfunction drugs risk STDs
    Men who took erectile dysfunction drugs such as Viagra were more likely to become infected with sexually transmitted diseases, including AIDS, U.S. researchers have reported. This infection rate was higher even in the year before the men got their...
  • Glaxo Removing Zinc From Denture Cream

    Glaxo Removing Zinc From Denture Cream
    WASHINGTON (AP) - GlaxoSmithKline said Thursday it will remove zinc from its denture cream, following reports that excessive use over many years can cause neurological damage and blood problems in consumers. The British manufacturer will cease...
  • High hopes for a malaria vaccine

    Each year, malaria kills more than 1 million people -- 90% of them in sub-Saharan Africa and 80% of them younger than 5 -- and makes 300 million people seriously ill. Major progress in controlling the disease has been made by the widespread adoption of...
  • Expectations affect benefits of pain drug

    Expectations affect benefits of pain drug
    People who don't believe their pain medicine will work can actually reduce or even cancel out the effectiveness of the drug, and images of their brains show how they are doing it, scientists report. Researchers from Britain and Germany used brain scans...
  • Wealthy nations must follow through on disease fight

    Wealthy nations must follow through on disease fight
    In 1980, I moved my family from Maryland to the White Mountain Apache Reservation in Arizona to work on an issue most people are not comfortable talking about — diarrhea. At the time, diarrhea, which is preventable and treatable, was rampantly...
  • Genital warts tied to range of cancers

    Genital warts tied to range of cancers
    NEW YORK (Reuters Health) - People who've ever had genital warts may have a somewhat higher risk of several types of cancer — possibly including common skin cancers, a new study suggests. The findings, reported in the Journal of Infectious...
  • Human Genome Sciences rebuffs $2.6 billion offer from GlaxoSmithKline

    Shares of Human Genome Sciences doubled in Thursday morning trading on news that a major British biopharmaceutical company offered to buy it for $2.6 billion, which the Rockville company rejected as too low. Human Genome, which uses the human DNA...